Bernstein SocGen cuts Ferrari stock price target on margin concerns

Ferrari’s first-quarter 2026 results beat expectations, with EPS of €2.69 versus €2.37 consensus, revenue of €2.14 billion versus €1.83 billion, and net industrial cash flow of €653 million, 25% ahead of expectations. EBIT margin was 29.7% reported and 30.9% underlying after a €41 million FX headwind, but Bernstein SocGen still cut its price target to $402 from $410 on concerns about slower second-half 2026 improvement and softer sequential upside. The shares fell 4% after the earnings call and now trade near a 52-week low.

Analysis

The market reaction looks more like a positioning and expectation problem than a fundamental break. When a luxury compounder beats on the P&L but still sells off, it usually means the buy-side was leaning on an even cleaner second-half acceleration story; that setup is fragile because the valuation already embeds scarcity and long-duration growth. The key second-order issue is that margin quality matters more than headline beat quality here: if currency normalizes but pricing/mix stops improving, the earnings power can still flatten even with strong reported growth.

The real debate is whether Ferrari is transitioning from a multiple story to a cash-flow story. If sequential ASP upside is capped in H2, the next leg up likely needs either a new product cycle or a re-rating from balance-sheet/capital-return optionality, not just another clean quarter. That means the stock could stay range-bound for months even if fundamentals remain excellent, because the marginal buyer is paying for acceleration, not stability.

The contrarian read is that the drawdown may be overdone if investors are extrapolating a temporary FX headwind and one quarter of normalizing expectations into a permanent de-rating. In a name with this much brand power and limited direct substitute risk, any further de-risking in sentiment can trigger a sharp mean reversion once estimates stop coming down. The better framing is not 'is Ferrari good?' but 'is the current price assuming too much incremental improvement from here?'

The main risk to the bearish thesis is a fast restoration of confidence if management re-anchors H2 with credible product/mix commentary or if the broader luxury complex catches a bid. Conversely, if macro weakens and high-end discretionary demand softens, this becomes a long-duration multiple compression trade rather than a one-off post-earnings dip. That distinction matters because the former can reverse in days, while the latter can take multiple quarters to fully price.

Key Decisions for Investors

• Consider a tactical long in RACE only on further weakness into the low-$300s with a 1-3 month horizon; use a tight stop below the 52-week low since the stock is already pricing in disappointment but not outright demand deterioration.
• For investors already long RACE, sell 1-2 month out-of-the-money covered calls to monetize elevated post-earnings volatility; this harvests premium while waiting for the market to re-anchor H2 expectations.
• For a cleaner expression of the 'expectations reset' view, pair short RACE against a stronger luxury compounder with more visible near-term catalysts over the next quarter; the trade works if Ferrari remains range-bound while the peer rerates on estimate revisions.
• If you want convexity, buy short-dated call spreads only after management commentary confirms sequential stabilization; the current setup is too dependent on narrative repair to justify outright calls today.
• Watch for a reversal trigger over the next 4-6 weeks: if consensus trims H2 numbers and the stock stops making new lows, cover shorts immediately because the valuation floor could attract strategic buyers.